TP53 and pancreatic neoplasm: The KPC mouse model supports the importance of p53 during tumor progression, and mice expressing TP53R172H concomitantly with KRasG12D in the pancreas (Pdx1-Cre) develop highly metastatic pancreatic tumors through the upregulation of PDGFRb, mimicking the human disease [32,33].